Toho Holdings Co., Ltd.
Notice Regarding Formulation of Medium-Term Management Plan 2026-2028 ‘Soaring into the Next Era’
Toho Holdings has formulated the Medium-Term Management Plan 2026-2028 'Soaring into the Next Era' for the three fiscal years from March 2027 to March 2029. The plan targets an operating income of over 30 billion yen, growth investments exceeding 50 billion yen, and shareholder returns exceeding 50 billion yen.
Key Figures
- Operating Income Target: Over 30 billion yen (Fiscal year ending March 2029)
- Growth Investment: Over 50 billion yen (Fiscal year ending March 2029)
- Shareholder Returns: Over 50 billion yen (During medium-term plan period)
AI要約
Overview of Medium-Term Management Plan 2026-2028
Toho Holdings has formulated the Medium-Term Management Plan 'Soaring into the Next Era' covering the three fiscal years from March 2027 to March 2029. Building on the foundation of the previous Medium-Term Management Plan 2023-2025 'Creating the Next Era', the plan focuses on achieving a significant leap in operating income as it enters a monetization phase. The company aims to strengthen the profitability of its pharmaceutical wholesale business, rapidly expand new businesses, and transform into a healthcare total solution provider.
Key Initiatives and Capital Policy
As part of the growth strategy, the company will enhance the pharmaceutical wholesale business, create new businesses, and expand its CDMO business. Efficiency strategies include cost structure reforms and promotion of digital transformation (DX). The capital policy aims for a total payout ratio of over 100% and DOE over 4%, planning stable dividend increases and flexible share buybacks. Investment plans include 10 billion yen for talent development, 25 billion yen for strengthening logistics functions, 8 billion yen for core system upgrades, with total growth investments exceeding 50 billion yen and shareholder returns surpassing 50 billion yen.
Toho Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
